Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited
- PMID: 1583731
- PMCID: PMC241168
- DOI: 10.1128/JVI.66.6.3823-3832.1992
Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited
Abstract
High concentrations of hemagglutinin-specific neutralizing polymeric monoclonal immunoglobulin A (IgA) inhibit attachment of the majority of type A influenza virus virions to cell monolayers and tracheal epithelium (H. P. Taylor and N. J. Dimmock, J. Exp. Med. 161:198-209, 1985; M. C. Outlaw and N. J. Dimmock, J. Gen. Virol. 71:69-76, 1990). A minority of virions attaches but is not infectious. Here, we report that a different mechanism operates when influenza virus A/Puerto Rico/8/34 (H1N1) is neutralized by low concentrations of monoclonal polymeric IgA or when A/fowl plague virus/Rostock/34 (H7N1) is neutralized by low concentrations of polyclonal rat secretory IgA. Under these conditions, neutralized virus attaches to cells and is taken up by them. However, upon entering the cell, the nucleoprotein (NP) of neutralized virus is found in the perinuclear cytoplasm, whereas NP from nonneutralized virus is concentrated in the nucleus itself. Further data show that the low-pH-mediated cell fusion activity of virions is inhibited by IgA in proportion to loss of infectivity. The possibilities that neutralization by low amounts of polymeric IgA is caused by inhibition of the virion fusion activity and that the aberrant distribution of NP from neutralized virus results from its failure to escape from the endosomal system were investigated by using A/PR/8/34 and the fusogenic agent polyethylene glycol (PEG) at pH 5.4. A/PR/8/34 attached to cells at 4 degrees C, with minimal internalization of the virus; treatment with PEG at pH 5.4 and 4 degrees C for 1 min led to infectious fusion of nonneutralized virus with the plasma membrane and, under these conditions, was more efficient than PEG at pH 7 or medium at pH 5.4. Neutralized virus which was attached to cells and treated with acidified PEG appeared to undergo primary and secondary uncoating, with its NP protein becoming concentrated in the nucleus and M1 becoming concentrated in the perinuclear cytoplasm. Although the distribution of NP and M1 was indistinguishable from infectious virus, infectivity was not restored. Thus, even when IgA-induced inhibition of fusion is reversed, virus is still neutralized. We suggest that infectious influenza virus undergoes an activation stage which may be the relaxation of the ribonucleoprotein structure needed to permit transcription or may be the removal of M1 bound to the ribonucleoprotein.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells.Virology. 1993 Aug;195(2):413-21. doi: 10.1006/viro.1993.1391. Virology. 1993. PMID: 8337821
-
Mechanisms of neutralization of influenza virus on mouse tracheal epithelial cells by mouse monoclonal polymeric IgA and polyclonal IgM directed against the viral haemagglutinin.J Gen Virol. 1990 Jan;71 ( Pt 1):69-76. doi: 10.1099/0022-1317-71-1-69. J Gen Virol. 1990. PMID: 2303801
-
Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies.J Virol. 1995 Feb;69(2):1339-43. doi: 10.1128/JVI.69.2.1339-1343.1995. J Virol. 1995. PMID: 7815518 Free PMC article.
-
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.Annu Rev Biochem. 2000;69:531-69. doi: 10.1146/annurev.biochem.69.1.531. Annu Rev Biochem. 2000. PMID: 10966468 Review.
-
Role of sulfatide in influenza A virus replication.Biol Pharm Bull. 2015;38(6):809-16. doi: 10.1248/bpb.b15-00119. Biol Pharm Bull. 2015. PMID: 26027821 Review.
Cited by
-
Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?Drugs Aging. 2004;21(6):349-59. doi: 10.2165/00002512-200421060-00001. Drugs Aging. 2004. PMID: 15084138 Review.
-
Evasion of influenza A viruses from innate and adaptive immune responses.Viruses. 2012 Sep;4(9):1438-76. doi: 10.3390/v4091438. Epub 2012 Sep 3. Viruses. 2012. PMID: 23170167 Free PMC article. Review.
-
When secretion turns into excretion - the different roles of IgA.Front Immunol. 2022 Dec 21;13:1076312. doi: 10.3389/fimmu.2022.1076312. eCollection 2022. Front Immunol. 2022. PMID: 36618388 Free PMC article. Review.
-
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions.Influenza Other Respir Viruses. 2019 Sep;13(5):429-437. doi: 10.1111/irv.12664. Epub 2019 Jun 21. Influenza Other Respir Viruses. 2019. PMID: 31225704 Free PMC article. Review.
-
Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.J Virol. 2001 Nov;75(21):10208-18. doi: 10.1128/JVI.75.21.10208-10218.2001. J Virol. 2001. PMID: 11581389 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous